Aner Gurvitz

1.3k total citations
40 papers, 1.1k citations indexed

About

Aner Gurvitz is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Aner Gurvitz has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 9 papers in Biochemistry and 5 papers in Pharmacology. Recurrent topics in Aner Gurvitz's work include Peroxisome Proliferator-Activated Receptors (17 papers), Microbial Metabolic Engineering and Bioproduction (13 papers) and Fungal and yeast genetics research (12 papers). Aner Gurvitz is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (17 papers), Microbial Metabolic Engineering and Bioproduction (13 papers) and Fungal and yeast genetics research (12 papers). Aner Gurvitz collaborates with scholars based in Austria, Finland and Australia. Aner Gurvitz's co-authors include Hanspeter Rottensteiner, J. Kalervo Hiltunen, Andreas Hartig, Alexander J. Kastaniotis, Barbara Hamilton, Helmut Ruis, Anu Mursula, Rik K. Wierenga, Maximilian Binder and Ian W. Dawes and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Aner Gurvitz

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aner Gurvitz Austria 18 967 188 111 87 86 40 1.1k
Mark T. McCammon United States 20 1.1k 1.2× 95 0.5× 80 0.7× 105 1.2× 140 1.6× 29 1.4k
Tatsuyuki Kamiryo Japan 21 857 0.9× 160 0.9× 76 0.7× 34 0.4× 45 0.5× 41 1.0k
Virginia McDonough United States 13 1.0k 1.0× 475 2.5× 254 2.3× 73 0.8× 51 0.6× 23 1.2k
Sarela García‐Santamarina Spain 15 628 0.6× 101 0.5× 87 0.8× 101 1.2× 45 0.5× 26 956
Joseph Stukey United States 13 1.1k 1.2× 519 2.8× 250 2.3× 77 0.9× 47 0.5× 15 1.4k
R. Bode Germany 15 556 0.6× 98 0.5× 42 0.4× 27 0.3× 75 0.9× 86 754
Peter Griač Slovakia 18 766 0.8× 235 1.3× 361 3.3× 60 0.7× 19 0.2× 38 991
Giorgia Letizia Marcone Italy 19 661 0.7× 188 1.0× 37 0.3× 24 0.3× 93 1.1× 27 1.0k
Alexandre Noiriel France 17 559 0.6× 139 0.7× 49 0.4× 35 0.4× 62 0.7× 40 852
Hans‐Joachim Schüller Germany 23 1.7k 1.8× 210 1.1× 368 3.3× 67 0.8× 73 0.8× 41 1.9k

Countries citing papers authored by Aner Gurvitz

Since Specialization
Citations

This map shows the geographic impact of Aner Gurvitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aner Gurvitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aner Gurvitz more than expected).

Fields of papers citing papers by Aner Gurvitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aner Gurvitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aner Gurvitz. The network helps show where Aner Gurvitz may publish in the future.

Co-authorship network of co-authors of Aner Gurvitz

This figure shows the co-authorship network connecting the top 25 collaborators of Aner Gurvitz. A scholar is included among the top collaborators of Aner Gurvitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aner Gurvitz. Aner Gurvitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gurvitz, Aner. (2010). Triclosan inhibition of mycobacterial InhA inSaccharomyces cerevisiae: yeast mitochondria as a novel platform for in vivo antimycolate assays. Letters in Applied Microbiology. 50(4). 399–405. 3 indexed citations
2.
Gurvitz, Aner, Fumi Suomi, Hanspeter Rottensteiner, J. Kalervo Hiltunen, & Ian W. Dawes. (2009). Avoiding unscheduled transcription in shared promoters:Saccharomyces cerevisiaeSum1p represses the divergent gene pairSPS18-SPS19through a midsporulation element (MSE). FEMS Yeast Research. 9(6). 821–831.
4.
Gurvitz, Aner. (2009). Identification of the Leishmania major Proteins LmjF07.0430, LmjF07.0440, and LmjF27.2440 as Components of Fatty Acid Synthase II. BioMed Research International. 2009(1). 950864–950864. 12 indexed citations
5.
Gurvitz, Aner & Hanspeter Rottensteiner. (2006). The biochemistry of oleate induction: Transcriptional upregulation and peroxisome proliferation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763(12). 1392–1402. 82 indexed citations
6.
Rottensteiner, Hanspeter, Ralf Erdmann, Barbara Hamilton, et al.. (2003). Saccharomyces cerevisiae PIP2 Mediating Oleic Acid Induction and Peroxisome Proliferation Is Regulated by Adr1p and Pip2p-Oaf1p. Journal of Biological Chemistry. 278(30). 27605–27611. 25 indexed citations
7.
Torkko, Juha M., Kari Koivuranta, Alexander J. Kastaniotis, et al.. (2003). Candida tropicalis Expresses Two Mitochondrial 2-Enoyl Thioester Reductases That Are Able to Form Both Homodimers and Heterodimers. Journal of Biological Chemistry. 278(42). 41213–41220. 29 indexed citations
8.
Gurvitz, Aner, et al.. (2002). Preliminary characterisation of , an essential gene related to of. FEMS Yeast Research. 2(2). 123–135. 6 indexed citations
9.
Kunze, Markus, Friedrich Kragler, Maximilian Binder, Andreas Hartig, & Aner Gurvitz. (2002). Targeting of malate synthase 1 to the peroxisomes of Saccharomyces cerevisiae cells depends on growth on oleic acid medium. European Journal of Biochemistry. 269(3). 915–922. 61 indexed citations
10.
Gurvitz, Aner, Barbara Hamilton, Helmut Ruis, Andreas Hartig, & J. Kalervo Hiltunen. (2001). Degradation of conjugated linoleic acid isomers in the yeast Saccharomyces cerevisiae. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1533(2). 81–85. 13 indexed citations
12.
Gurvitz, Aner, J. Kalervo Hiltunen, Ralf Erdmann, et al.. (2001). Saccharomyces cerevisiae Adr1p Governs Fatty Acid β-Oxidation and Peroxisome Proliferation by RegulatingPOX1 and PEX11. Journal of Biological Chemistry. 276(34). 31825–31830. 53 indexed citations
14.
Gurvitz, Aner, Hanspeter Rottensteiner, Ian W. Dawes, et al.. (2000). Adr1p-Dependent Regulation of the Oleic Acid-Inducible Yeast Gene SPS19 Encoding the Peroxisomal β-Oxidation Auxiliary Enzyme 2,4-Dienoyl-CoA Reductase. PubMed. 4(2). 81–89. 25 indexed citations
15.
Gurvitz, Aner, Barbara Hamilton, Andreas Hartig, et al.. (1999). A novel element in the promoter of the Saccharomyces cerevisiae gene SPS19 enhances ORE-dependent up-regulation in oleic acid and is essential for de-repression. Molecular and General Genetics MGG. 262(3). 481–492. 13 indexed citations
16.
Gurvitz, Aner, Anu Mursula, Barbara Hamilton, et al.. (1998). Peroxisomal Δ3-cis-Δ2-trans-Enoyl-CoA Isomerase Encoded by ECI1 Is Required for Growth of the Yeast Saccharomyces cerevisiae on Unsaturated Fatty Acids. Journal of Biological Chemistry. 273(47). 31366–31374. 53 indexed citations
17.
Gurvitz, Aner, Hanspeter Rottensteiner, Barbara Hamilton, et al.. (1998). Fate and role of peroxisomes during the life cycle of the yeast Saccharomyces cerevisiae : inheritance of peroxisomes during meiosis. Histochemistry and Cell Biology. 110(1). 15–26. 12 indexed citations
19.
Gurvitz, Aner, et al.. (1994). Carrier detection in X‐linked retinitis pigmentosa. Australian and New Zealand Journal of Ophthalmology. 22(2). 111–113. 2 indexed citations
20.
Neilan, Brett A., et al.. (1993). Rapid preparation of limited biological samples for small-volume PCR.. Genome Research. 2(3). 261–262. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026